Global Therapeutic Nuclear Medicines Market Research Report 2019-2025

Published On: January 2019 | Report ID: 121039 | Category: Pharmaceuticals and HealthcarePages: 95

The global Therapeutic Nuclear Medicines market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on Therapeutic Nuclear Medicines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Nuclear Medicines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Cardinal Health

Mallinckrodt

GE Healthcare

Lantheus Medical Imaging

Bayer

Bracco Imaging

Eczacibasi-Monrol Nuclear Products

Nordion

Advanced Accelerator Applications

IBA Molecular Imaging

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Beta Emitters

Alpha Emitters

Brachytherapy Products

Segment by Application

Thyroid

Bone Metastasis

Lymphoma

Endocrine Tumors

Others

Table of Contents

Executive Summary

1 Therapeutic Nuclear Medicines Market Overview

1.1 Product Overview and Scope of Therapeutic Nuclear Medicines

1.2 Therapeutic Nuclear Medicines Segment by Type

1.2.1 Global Therapeutic Nuclear Medicines Production Growth Rate Comparison by Type (2014-2025)

1.2.2 Beta Emitters

1.2.3 Alpha Emitters

1.2.4 Brachytherapy Products

1.3 Therapeutic Nuclear Medicines Segment by Application

1.3.1 Therapeutic Nuclear Medicines Consumption Comparison by Application (2014-2025)

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Endocrine Tumors

1.3.6 Others

1.3 Global Therapeutic Nuclear Medicines Market by Region

1.3.1 Global Therapeutic Nuclear Medicines Market Size Region

1.3.2 North America Status and Prospect (2014-2025)

1.3.3 Europe Status and Prospect (2014-2025)

1.3.4 China Status and Prospect (2014-2025)

1.3.5 Japan Status and Prospect (2014-2025)

1.3.6 Southeast Asia Status and Prospect (2014-2025)

1.3.7 India Status and Prospect (2014-2025)

1.4 Global Therapeutic Nuclear Medicines Market Size

1.4.1 Global Therapeutic Nuclear Medicines Revenue (2014-2025)

1.4.2 Global Therapeutic Nuclear Medicines Production (2014-2025)

2 Global Therapeutic Nuclear Medicines Market Competition by Manufacturers

2.1 Global Therapeutic Nuclear Medicines Production Market Share by Manufacturers (2014-2019)

2.2 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2014-2019)

2.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2014-2019)

2.4 Manufacturers Therapeutic Nuclear Medicines Production Sites, Area Served, Product Types

2.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends

2.5.1 Therapeutic Nuclear Medicines Market Concentration Rate

2.5.2 Therapeutic Nuclear Medicines Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Therapeutic Nuclear Medicines Production Market Share by Regions

3.1 Global Therapeutic Nuclear Medicines Production Market Share by Regions

3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2014-2019)

3.3 Global Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

3.4 North America Therapeutic Nuclear Medicines Production

3.4.1 North America Therapeutic Nuclear Medicines Production Growth Rate (2014-2019)

3.4.2 North America Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

3.5 Europe Therapeutic Nuclear Medicines Production

3.5.1 Europe Therapeutic Nuclear Medicines Production Growth Rate (2014-2019)

3.5.2 Europe Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

3.6 China Therapeutic Nuclear Medicines Production (2014-2019)

3.6.1 China Therapeutic Nuclear Medicines Production Growth Rate (2014-2019)

3.6.2 China Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

3.7 Japan Therapeutic Nuclear Medicines Production (2014-2019)

3.7.1 Japan Therapeutic Nuclear Medicines Production Growth Rate (2014-2019)

3.7.2 Japan Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Therapeutic Nuclear Medicines Consumption by Regions

4.1 Global Therapeutic Nuclear Medicines Consumption by Regions

4.2 North America Therapeutic Nuclear Medicines Consumption (2014-2019)

4.3 Europe Therapeutic Nuclear Medicines Consumption (2014-2019)

4.4 China Therapeutic Nuclear Medicines Consumption (2014-2019)

4.5 Japan Therapeutic Nuclear Medicines Consumption (2014-2019)

5 Global Therapeutic Nuclear Medicines Production, Revenue, Price Trend by Type

5.1 Global Therapeutic Nuclear Medicines Production Market Share by Type (2014-2019)

5.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2014-2019)

5.3 Global Therapeutic Nuclear Medicines Price by Type (2014-2019)

5.4 Global Therapeutic Nuclear Medicines Production Growth by Type (2014-2019)

6 Global Therapeutic Nuclear Medicines Market Analysis by Applications

6.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2014-2019)

6.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business

7.1 Cardinal Health

7.1.1 Cardinal Health Therapeutic Nuclear Medicines Production Sites and Area Served

7.1.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.1.3 Cardinal Health Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.1.4 Main Business and Markets Served

7.2 Mallinckrodt

7.2.1 Mallinckrodt Therapeutic Nuclear Medicines Production Sites and Area Served

7.2.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.2.3 Mallinckrodt Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.2.4 Main Business and Markets Served

7.3 GE Healthcare

7.3.1 GE Healthcare Therapeutic Nuclear Medicines Production Sites and Area Served

7.3.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.3.3 GE Healthcare Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.3.4 Main Business and Markets Served

7.4 Lantheus Medical Imaging

7.4.1 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production Sites and Area Served

7.4.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.4.4 Main Business and Markets Served

7.5 Bayer

7.5.1 Bayer Therapeutic Nuclear Medicines Production Sites and Area Served

7.5.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.5.3 Bayer Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.5.4 Main Business and Markets Served

7.6 Bracco Imaging

7.6.1 Bracco Imaging Therapeutic Nuclear Medicines Production Sites and Area Served

7.6.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.6.3 Bracco Imaging Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.6.4 Main Business and Markets Served

7.7 Eczacibasi-Monrol Nuclear Products

7.7.1 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Production Sites and Area Served

7.7.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.7.4 Main Business and Markets Served

7.8 Nordion

7.8.1 Nordion Therapeutic Nuclear Medicines Production Sites and Area Served

7.8.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.8.3 Nordion Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.8.4 Main Business and Markets Served

7.9 Advanced Accelerator Applications

7.9.1 Advanced Accelerator Applications Therapeutic Nuclear Medicines Production Sites and Area Served

7.9.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.9.4 Main Business and Markets Served

7.10 IBA Molecular Imaging

7.10.1 IBA Molecular Imaging Therapeutic Nuclear Medicines Production Sites and Area Served

7.10.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification

7.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Production, Revenue, Price and Gross Margin (2014-2019)

7.10.4 Main Business and Markets Served

8 Therapeutic Nuclear Medicines Manufacturing Cost Analysis

8.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

8.4 Therapeutic Nuclear Medicines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.2 Therapeutic Nuclear Medicines Distributors List

9.3 Therapeutic Nuclear Medicines Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities

10.3 Market Drivers

10.4 Challenges

10.5 Influence Factors

11 Global Therapeutic Nuclear Medicines Market Forecast

11.1 Global Therapeutic Nuclear Medicines Production, Revenue Forecast

11.1.1 Global Therapeutic Nuclear Medicines Production Growth Rate Forecast (2019-2025)

11.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2019-2025)

11.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2019-2025)

11.2 Global Therapeutic Nuclear Medicines Production Forecast by Regions (2019-2025)

11.2.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2019-2025)

11.2.2 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2019-2025)

11.2.3 China Therapeutic Nuclear Medicines Production, Revenue Forecast (2019-2025)

11.2.4 Japan Therapeutic Nuclear Medicines Production, Revenue Forecast (2019-2025)

11.3 Global Therapeutic Nuclear Medicines Consumption Forecast by Regions (2019-2025)

11.3.1 North America Therapeutic Nuclear Medicines Consumption Forecast (2019-2025)

11.3.2 Europe Therapeutic Nuclear Medicines Consumption Forecast (2019-2025)

11.3.3 China Therapeutic Nuclear Medicines Consumption Forecast (2019-2025)

11.3.4 Japan Therapeutic Nuclear Medicines Consumption Forecast (2019-2025)

11.4 Global Therapeutic Nuclear Medicines Production, Revenue and Price Forecast by Type (2019-2025)

11.5 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Author List

13.4 Disclaimer

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.